Skin tumours in the West of Scotland renal transplant population

British Journal of Dermatology

Volumn 168, Issue 5, 2013, Pages 1047-1053

  Mackintosh, L J ^a   Geddes, C C ^a   Herd, R M ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELANOMA; PREVALENCE; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; RISK FACTORS; SCOTLAND; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84877004800     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12129     Document Type: Article

References (29)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-12.
2. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-9.
3. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13.
4. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-7.
5. National Institute for Health and Clinical Excellence. Improving outcomes for patients with skin tumours including melanoma. Available at: http://guidance.nice.org.uk/CSGSTIM/Guidance (last accessed 20 November 2012).
6. Penn I,. Posttransplant malignancies. Transplant Proc 1999; 31: 1260-2.
7. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-21.
8. Ramsay HM, Fryer AA, Hawley CM, et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950-6.
9. Webb MC, Compton F, Andrews PA, Koffman CG,. Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997; 29: 828-30.
10. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-9.
11. Cohen EB, Komorowski RA, Clowry LJ,. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987; 88: 32-7.
12. Hardie IR, Strong RW, Hartley LC, et al. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87: 177-83.
13. Hollenbeak CS, Todd MM, Billingsley EM, et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005; 104: 1962-7.
14. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
15. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS,. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-19.
16. Moosa MR, Gralla J,. Skin cancer in renal allograft recipients-experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005; 19: 735-41.
17. Carroll RP, Ramsay HM, Fryer AA, et al. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003; 41: 676-83.
18. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
19. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479-84.
20. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504.
21. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574-9.
22. Liddington M, Richardson AJ, Higgins RM, et al. Skin cancer in renal transplant recipients. Br J Surg 1989; 76: 1002-5.
23. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221-6.
24. Marcen R, Pascual J, Tato AM, et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35: 1714-16.
25. Staples M, Marks R, Giles G,. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-8.
26. Proby CM, Wisgerhof HC, Casabonne D, et al. The epidemiology of transplant-associated keratinocyte cancers in different geographical regions. In: Skin Cancer After Organ Transplantation (, Stockfleth E, Ulrich C, Euvrard S, Proby C, Bouwes Bavinck JN, Geissler EK, eds). New York: Springer, 2009; 75-95.
27. Koehl GE, Andrassy J, Guba M, et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 2004; 77: 1319-26.
28. MacDonald AS,. Cancer and transplantation intersect at the mammalian target of rapamycin. Transplantation 2007; 84: 682-4.
29. Campbell SB, Walker R, See Tai S, et al. Randomized controlled trial for renal transplant recipients at high risk for nonmelanoma skin cancer. Am J Transplant 2012; 12: 1146-56.